Related references
Note: Only part of the references are listed.
Article
Rheumatology
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis - A phase I/II randomized, blinded, placebo-controlled, dose-ranging study
Mark C. Genovese et al.
ARTHRITIS AND RHEUMATISM (2008)
Share Paper
